CW October 2002Issue Number 10 October 2002 ISSN 10593802 Arsenic Trioxide Inhibits Growth in Multiple MyelomaArsenic trioxide (As2O3) has a colorful history as a murder tool, poison and generally dangerous substance. It is also an ancient drug, having been used indiscriminately in the past for various diseases, albeit in very small amounts. Apart from its status as a homeopath, there was no formal definition of its use in modern medicine. Only in a recent revival of some half-forgotten agents, such as thalidomide and some proteasome inhibitors, has arsenic trioxide joined the welcome ranks of promising anticancer agents. It can even slow progression in myelodysplastic syndromes, such as leukemia and multiple myeloma.
Go to Previous Page Go to Next Page Source & Additional Reading K. C. Anderson et al., Molecul. Cancer Therapeut. 1: 851-860, 2002. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |